Patterson reports consolidated sales of $820,084,000 for third-quarter of fiscal 2010
Posted on February 18th, 2010 in Stem Cell Therapy, Stem Cells
Patterson Companies, Inc. today reported consolidated sales of $820,084,000 for the third quarter of fiscal 2010 ended January 23, an increase of 1% from $811,023,000 in the year-earlier quarter. Net income of $56,049,000 or $.47 per diluted share rose 6% from $52,807,000 or $0.45 per diluted share in the third quarter of fiscal 2009.
Tags:
